Hedge Funds ◦ Managed Futures ◦ Crypto Funds ◦ Venture Capital ◦ Private Equity ◦ Real Estate ◦ Cannabis

(formerly HedgeMaven)

(formerly HedgeMaven)

Free ◦ Private ◦ Secure

Most Visited Alternative Investment Industry Website. Over 40,000 visitors per month

4d ago fiercebiotech Views: 35

SR One has backed biotech companies for decades as GlaxoSmithKline’s venture arm. Now, the firm is striking out on its own, having spun out from the British conglomerate and raised a whopping $500 million fund. The fund, SR One’s first, will back “elite” biotechs on both sides of the Atlantic, working on new medicines to address treatment gaps. -

Venture Capital Headlines:

Venture Capital
Join the AlphaMaven Private Investment Network

Exclusively For:

Qualified Investors & Knowledgeable Industry Participants

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates